Literature DB >> 25978844

Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense.

Rolf Schreckenberg1, Manuel Rebelo1, Alexander Deten2, Martin Weber1, Susanne Rohrbach1, Márton Pipicz3,4, Csaba Csonka3,4, Péter Ferdinandy3,5, Rainer Schulz1, Klaus-Dieter Schlüter1.   

Abstract

AIMS: Research into right ventricular (RV) physiology and identification of pathomechanisms underlying RV failure have been neglected for many years, because function of the RV is often considered less important for overall hemodynamics and maintenance of blood circulation. In view of this, this study focuses on identifying specific adaptive mechanisms of the RV and left ventricle (LV) during a state of chronic nitric oxide (NO) deficiency, one of the main causes of cardiac failure. NO deficiency was induced in rats by L-NAME feeding over a 4 week period. The cardiac remodeling was then characterized separately for the RV/LV using quantitative real-time polymerase chain reaction, histology, and functional measurements.
RESULTS: Only the RV underwent remodeling that corresponded morphologically and functionally with the pattern of dilated cardiomyopathy. Symptoms in the LV were subtle and consisted primarily of moderate hypertrophy. A massive increase in reactive oxygen species (ROS) (+4.5±0.8-fold, vs. control) and a higher degree of oxidized tropomyosin (+46%±4% vs. control) and peroxynitrite (+32%±2% vs. control) could be identified as the cause of both RV fibrosis and contractile dysfunction. The expression of superoxide dismutase-2 was specifically increased in the LV by 51%±3% and prevented the ROS increase and the corresponding structural and functional remodeling. INNOVATION: This study identified the inability of the RV to increase its antioxidant capacity as an important risk factor for developing RV failure.
CONCLUSION: Unlike the LV, the RV did not display the necessary adaptive mechanisms to cope with increased oxidative stress during a state of chronic NO deficiency.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25978844      PMCID: PMC4657518          DOI: 10.1089/ars.2014.6139

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  49 in total

1.  Right ventricular myocardium derives from the anterior heart field.

Authors:  Stéphane Zaffran; Robert G Kelly; Sigolène M Meilhac; Margaret E Buckingham; Nigel A Brown
Journal:  Circ Res       Date:  2004-06-24       Impact factor: 17.367

2.  Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension.

Authors:  J Bauersachs; A Bouloumié; D Fraccarollo; K Hu; R Busse; G Ertl
Journal:  Eur J Pharmacol       Date:  1998-11-27       Impact factor: 4.432

3.  Oxidation of myofibrillar proteins in human heart failure.

Authors:  Marcella Canton; Sara Menazza; Freya L Sheeran; Patrizia Polverino de Laureto; Fabio Di Lisa; Salvatore Pepe
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

4.  Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure.

Authors:  B J Baker; M M Wilen; C M Boyd; H Dinh; J A Franciosa
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

5.  Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.

Authors:  I F Benzie; B Tomlinson
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

Review 6.  Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart.

Authors:  M L Handoko; F S de Man; C P Allaart; W J Paulus; N Westerhof; A Vonk-Noordegraaf
Journal:  Eur Respir Rev       Date:  2010-03

Review 7.  Role of nitric oxide in cardiovascular disease: focus on the endothelium.

Authors:  R O Cannon
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

8.  Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress.

Authors:  Subramanian Kumar; Pichavaram Prahalathan; Boobalan Raja
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-19       Impact factor: 3.000

9.  Reactions of captopril and epicaptopril with transition metal ions and hydroxyl radicals: an EPR spectroscopy study.

Authors:  V Misík; I T Mak; R E Stafford; W B Weglicki
Journal:  Free Radic Biol Med       Date:  1993-12       Impact factor: 7.376

Review 10.  Right ventricular function and failure: a review.

Authors:  R Hines
Journal:  Yale J Biol Med       Date:  1991 Jul-Aug
View more
  17 in total

Review 1.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

Review 2.  Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure.

Authors:  J Heger; R Schulz; G Euler
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

3.  Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension.

Authors:  A Zimmer; R B Teixeira; J H P Bonetto; A C Bahr; P Türck; A L de Castro; C Campos-Carraro; F Visioli; T R Fernandes-Piedras; K R Casali; C M C Scassola; G Baldo; A S Araujo; P Singal; A Belló-Klein
Journal:  Mol Cell Biochem       Date:  2019-11-14       Impact factor: 3.396

4.  Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions.

Authors:  Gregory J Bittle; David Morales; Kristopher B Deatrick; Nathaniel Parchment; Progyaparamita Saha; Rachana Mishra; Sudhish Sharma; Nicholas Pietris; Alexander Vasilenko; Casey Bor; Chetan Ambastha; Muthukumar Gunasekaran; Deqiang Li; Sunjay Kaushal
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

5.  Effect of nitric oxide deficiency on the pulmonary PTHrP system.

Authors:  Bastian Brockhoff; Rolf Schreckenberg; Svenja Forst; Jacqueline Heger; Péter Bencsik; Krisztina Kiss; Peter Ferdinandy; Rainer Schulz; Klaus-Dieter Schlüter
Journal:  J Cell Mol Med       Date:  2016-08-31       Impact factor: 5.310

6.  Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.

Authors:  Klaus-Dieter Schlüter; Annemarie Wolf; Martin Weber; Rolf Schreckenberg; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2017-09-14       Impact factor: 17.165

Review 7.  Redox Biology of Right-Sided Heart Failure.

Authors:  Nataliia V Shults; Oleksiy Melnyk; Dante I Suzuki; Yuichiro J Suzuki
Journal:  Antioxidants (Basel)       Date:  2018-08-08

8.  Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing.

Authors:  Azadeh Esfandiary; Hanna S Kutsche; Rolf Schreckenberg; Martin Weber; Oleg Pak; Baktybek Kojonazarov; Akylbek Sydykov; Christine Hirschhäuser; Annemarie Wolf; Daniela Haag; Matthias Hecker; Ludger Fink; Werner Seeger; Hossein A Ghofrani; Ralph T Schermuly; Norbert Weißmann; Rainer Schulz; Susanne Rohrbach; Ling Li; Natascha Sommer; Klaus-Dieter Schlüter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

9.  New Aspects in the Diagnosis and Therapy of Fetal Hypoplastic Left Heart Syndrome.

Authors:  Oliver Graupner; Christian Enzensberger; Roland Axt-Fliedner
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

10.  Autocrine effects of PCSK9 on cardiomyocytes.

Authors:  Annemarie Wolf; Hanna Sarah Kutsche; Rolf Schreckenberg; Martin Weber; Ling Li; Susanne Rohrbach; Rainer Schulz; Klaus-Dieter Schlüter
Journal:  Basic Res Cardiol       Date:  2020-11-10       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.